Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login

The Controversial use of Aducanumab (Aduhelm) for Alzheimer’s Disorder  

By: Aamir S. Dave, PharmD Candidate c/o 2023 Judith L. Beizer, PharmD, BCGP, FASCP, AGSF Alzheimer’s and Dementia              Dementia is characterized by the loss of memory and other cognitive abilities that interfere with daily life. Alzheimer’s is a progressive neurological disease and is the most common type of dementia, accounting for greater than 60-80%…

Continue reading →

Molnupiravir: A Prospective Oral Antiviral for Treatment of COVID-19  

By: Justin Budz, PharmD Candidate c/o 2023              On January 19th, 2020, a 35-year-old man in an urgent care clinic in Snohomish County, Washington was the first to be confirmed by the Centers for Disease Control and Prevention (CDC) to be infected with Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2…

Continue reading →

CDC Expands Eligibility for COVID-19 Booster Shots  

By: Fatima Amjad, PharmD candidate c/o 2022              Pharmacists have truly taken on the role of superhero during the coronavirus disease 2019 (COVID-19) pandemic. As of April 6, 2022 more than 239.1 million COVID-19 vaccine doses have been administered by community pharmacies across the United States.1 Community pharmacists have gone above and beyond immunizing eligible…

Continue reading →

A Review of A Randomized Trial of a Transglutaminase-2 Inhibitor for Celiac Disease  

By: Natalia Jucha, PharmD Candidate c/o 2022 and Helen Li, PharmD Candidate c/o 2023              Celiac disease is classified as an autoimmune disorder and occurs in individuals who cannot tolerate gluten. Dietary gluten induces an immune response and causes damage to the small intestine, particularly the duodenum and proximal jejunum. A small peptide called gliadin,…

Continue reading →

Cabenuva: A Monthly Injectable for the Treatment of HIV-1

By: Sharon Joseph PharmD Candidate c/o 2022 and Salma Hewady, PharmD               Human immunodeficiency virus (HIV) is a single-stranded retrovirus that attacks the immune system, predisposing the host to opportunistic infections and malignancies. If not properly treated, HIV can progress to Acquired Immunodeficiency Syndrome (AIDS). Goals of therapy include restoration of immune function, suppression of…

Continue reading →

(Volume 11, Issue 3)
A Review of A Randomized Trial of a Transglutaminase-2 Inhibitor for Celiac Disease  

CDC Expands Eligibility for COVID-19 Booster Shots  

Molnupiravir: A Prospective Oral Antiviral for Treatment of COVID-19  

The Controversial use of Aducanumab (Aduhelm) for Alzheimer’s Disorder  

YouTube Bans Misinformation About Approved Vaccines  

View Full Issue

Do You Want to be a Published Author? Submit your Article(s) Today!


 Tweets by @RhoChiPost
HOME: Home Page

VOLUMES / ISSUES: 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List

Copyright © 2011-2022 Rho Chi Post